Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.
2.
3.

Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.

Yang HY, Yang SY, Shao FY, Wang HY, Wang YD.

Asian Pac J Cancer Prev. 2015;16(2):495-500.

4.

X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.

Zeng FR, Ling Y, Yang J, Tian XC, Yang X, Luo RC.

Tumour Biol. 2013 Feb;34(1):555-63. doi: 10.1007/s13277-012-0581-2. Epub 2012 Nov 28.

PMID:
23188703
5.

Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.

Li J, Li Z, Feng L, Guo W, Zhang S.

Tumour Biol. 2013 Feb;34(1):261-9. doi: 10.1007/s13277-012-0546-5. Epub 2012 Oct 6.

PMID:
23055199
6.

XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.

Qi Y, Cui L, Song Y, Li N.

Mol Biol Rep. 2014 Feb;41(2):879-87. doi: 10.1007/s11033-013-2929-0. Epub 2014 Jan 4.

PMID:
24390232
7.

Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.

Dong LM, Zhang XY, Teng H, Li MS, Wang P.

Genet Mol Res. 2014 Nov 28;13(4):9976-85. doi: 10.4238/2014.November.28.2.

8.

XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.

Dai L, Wang K, Zhang J, Lv Q, Wu X, Wang Y.

Int J Cancer. 2009 Sep 1;125(5):1102-9. doi: 10.1002/ijc.24446.

9.

XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.

Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M.

Liver Int. 2011 Jul;31(6):802-9. doi: 10.1111/j.1478-3231.2011.02508.x. Epub 2011 Mar 21. Review.

PMID:
21645210
10.

Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population.

Choudhury JH, Choudhury B, Kundu S, Ghosh SK.

Med Oncol. 2014 Aug;31(8):67. doi: 10.1007/s12032-014-0067-8. Epub 2014 Jun 24.

PMID:
24958516
11.

Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.

Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC.

PLoS One. 2013;8(1):e55597. doi: 10.1371/journal.pone.0055597. Epub 2013 Jan 30.

12.

Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.

Wu W, Liu L, Yin Z, Guan P, Li X, Zhou B.

PLoS One. 2014 Jan 30;9(1):e86798. doi: 10.1371/journal.pone.0086798. eCollection 2014.

13.

XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Huang Y, Xie D, Tang N, Wang J, Zeng X, Zhao P, He L.

Tumour Biol. 2014 Jan;35(1):799-808. doi: 10.1007/s13277-013-1110-7. Epub 2013 Aug 30.

PMID:
23990457
14.

XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.

Hu Z, Hu X, Long J, Su L, Wei B.

Gene. 2013 Oct 10;528(2):67-73. doi: 10.1016/j.gene.2013.07.005. Epub 2013 Jul 17.

PMID:
23872202
15.

Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.

Wu D, Jiang H, Gu Q, Zhang D, Li Z.

Tumour Biol. 2013 Oct;34(5):3265-9. doi: 10.1007/s13277-013-0899-4. Epub 2013 Jun 19. Retraction in: Tumour Biol. 2017 Apr 20;:.

PMID:
23780894
16.

XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.

Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z.

Prostate Cancer Prostatic Dis. 2011 Sep;14(3):225-31. doi: 10.1038/pcan.2011.26. Epub 2011 Jun 7.

PMID:
21647176
17.

X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls.

Zhang L, Qiu Z, Luo J, Shu W.

Neural Regen Res. 2012 Oct 15;7(29):2313-9. doi: 10.3969/j.issn.1673-5374.2012.29.011.

18.
19.

DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.

Trabulus S, Guven GS, Altiparmak MR, Batar B, Tun O, Yalin AS, Tunckale A, Guven M.

Mol Biol Rep. 2012 Jun;39(6):6995-7001. doi: 10.1007/s11033-012-1529-8.

PMID:
22302399
20.

Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.

Mutlu P, Mutlu M, Yalcin S, Unsoy G, Yaylaci A, Saylam G, Akin I, Korkmaz H, Gunduz U.

J BUON. 2015 Mar-Apr;20(2):540-7.

PMID:
26011347

Supplemental Content

Support Center